C. Filliter

First name

C.

Last name

Filliter

Engler, J., Filliter, C., Montastruc, F., Abenhaim, H., Rej, S., & Renoux, C. (2024). Risk of abnormal uterine bleeding associated with high-affinity compared with low-affinity serotonin and norepinephrine reuptake inhibitors. J Affect Disord, 350, 813-821. http://doi.org/10.1016/j.jad.2024.01.163

View

Larose, S., Filliter, C., Platt, R. W., H. Y. Yu, O., & Filion, K. B. (2023). Long-acting insulin analogues and the risk of diabetic retinopathy among patients with type 2 diabetes: A population-based cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.15106

View

Aloe, S., Filliter, C., Salmasi, S., Igweokpala, S., H. Y. Yu, O., Tagalakis, V., & Filion, K. B. (2023). SGLT2 Inhibitors and the Risk of Venous Thromboembolism: A Population-based Cohort Study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.15787

View

Cao, T. X. D., Filliter, C., Montastruc, F., H. Y. Yu, O., Fergusson, E., Rej, S., et al. (2022). Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths. J Affect Disord, 318, 231-237. http://doi.org/10.1016/j.jad.2022.08.094

View